VIEWS: 382 PAGES: 12 POSTED ON: 5/31/2010
PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Denis Chetverikov General Manager in Russia Teva Pharmaceutical Industries Ltd. Education Degree, Medical University of Nizhniy Novgorod, Russia, 1995. Executive management courses with MCE, Brussels. Krauthammer International Professional Background Started career in the pharmaceutical business as a representative with Organon B.V., followed by a six years with F. Hoffman La Roche and Abbot in different sales and marking positions, ranging from business unit manager to national sales manager. Joined IVAX in January 2002 as a national sales and marketing manager. In September, 2008 moved to the International Marketing Department, focusing on the countries of the Commonwealth of Independent States and Middle East and North Africa. From April to June 2003, was the interim country manager for Ukraine. Was appointed to the position of country manager for Russia in August 2003. After the merger of Teva and IVAX in January 2006, was appointed general manager of the new joint Teva operation in Russia. Company Profile Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe. In Russia, Teva specializes in such segments as CNS, respiratory, oncology and biotechnology, BMU, virus diseases and OTC products. Teva’s product portfolio in Russia also includes innovative products. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Victor Dmitriev General Director Association of Russian Pharmaceutical Manufacturers Education Medical doctor, graduated from the Sechenov First Moscow Medical Institute. Professional Background Victor was one of the originators of the Association of Russian Pharmaceutical Manufacturers (ARPM) in 2002 and managed the Association until 2004. From 2004 till 2007 Victor worked in the capacity of deputy Director of the Federal State Institution Scientific Center for Expert Examination of Medical Drugs. In October 2007 Victor Dmitriev was re- elected to the position of ARPM General Director by a decision of the Association General Meeting. Company Profile The Association of Russian Pharmaceutical Manufacturers (APRM) was founded in 2002. The APRM comprises 16 leading Russian pharmaceutical enterprises including 29 factories accounting for over 50% of pharmaceuticals produced in Russia, 40% of export, 70% of domestic drugs for the ONLS program (Necessary Drugs Support). The ARPM mission is to develop Russian pharmaceutical industry that will be able to provide the population of Russia with necessary up-to-date high-quality and affordable drugs. The Association activity is aimed at the increase of competition in Russian pharmaceutical industry and at promotion of integrating the Russian pharmaceutical industry into the world market while retaining and increasing the production and financial potential of the industry enterprises. The APRM is a member of Chamber of Trade and Commerce of the Russian Federation, it actively cooperates with specialized Federal authorities: the Ministry of Public Health and Social Development of the Russian Federation, the Federal Service for the Supervision of Public Health and Social Development, the Ministry of Industry and Trade of the RF, the Federal Agency for Technical Regulation and Metrology, the State Duma Committee for Health Protection. According to the results of 2007 the ARPM won the 1st prize in nomination «Best Public Organization» of the Platinum Ounce open contest of pharmaceutical market professionals. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Dmitry Efimov General Director Nizhpharm Education In 1997 Dmitry graduated from the Department of Economy of Nizhny Novgorod State University. In 2001 he studied in the USA (the Presidential training program), and took a training course of the Dutch Center of Managers Suppor de Baak (Dynamic Business Management). In 2007 he graduated from IEDC Bled School of Management (Slovenia) receiving a degree in PMBA. Professional Background Dmitry Efimov started his career at Nizhpharm Company as analyst manager in 1996 right after his graduation from the University. The total length of service at the company is over 12 years. Throughout his work at Nizhpharm Dmitry successively occupied the positions of the leading economist, head of strategic planning department. From 2004 through 2007 he managed the company financial department in the capacity of Financial Director. In March 2007 Dmitry was appointed General Director of Nizhpharm Company and Vice-President of STADA for Russia and the CIS. Company Profile STADA CIS is the Russian pharmaceutical holding, which is part of STADA international group, was established as a result of a merger and reorganization of Nizhpharm and Markiz- Pharma companies. The holding includes companies of thee lines of activity: STADA PharmDevelopment – development of drugs; STADA Marketing (Russia), STADA Ukraine, STADA Central Asia (Kazakhstan, Uzbekistan) — marketing and sales; NIZHPHARM (Nizhny Novgorod), MARKIZ-PHARMA (Moscow), SKOPINPHARM (Ryazan region) – manufacture of drugs. All holding production sites comply with the GMP standards. Currently the united STADA CIS product portfolio includes more than 100 names of pharmaceuticals of various ATC classes and of different forms. According to Pharmexpert Center of Marketing Research, the merged company has the third position among Russian pharmaceutical manufacturers in terms of the production volume according to the results of the first six months of 2008, with a share of 9.76% of the total amount of Russian pharmaceutical output. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Svetlana Kosheleva Acting general director Pharmacy chain «Doctor Stoletov» Education In 1986 graduated pharmaceutical faculty of Medical Aсademy of Moscow I.A. Sechenov. Professional Background During 1986 - 1995 has passed a way from the pharmacist to a manager of drugstore. 1995 - 1997 - the director of department of pharmacy chain «MultyPharma». 1997-2000 – commercial director of JSC «Apteki 36, 6». 2001-2006 – deputy general director of pharmacy chain «Rigla». 2006- 2008 – the general director of «Pharmacy chain О3». April 2008 – 17th November 2008 - the first deputy general director of pharmacy chain «Doctor Stoletov». Since 17th November 2008 Svetlana Kosheleva - Acting general director of pharmacy chain «Doctor Stoletov». Company Profile Pharmacy chain «Doctor Stoletov» was established in 1994. Nowadays pharmacy chain «Doсtor Stoletov» operates 480 drugstores in 18 regions: Moscow end Moscow region, Saratov region, Krasnodar region, Stavropol region, Adygea, Rostov region, Volgograd region, Belgorod region, Orenburg region, Kursk region, Orel region, Tula, Tatarstan, Lipetsk, Novosibirsk, Magnitogorsk, Yaroslavl. «Doсtor Stoletov» ranked as 4 place in Russian pharmacy chains (according to «Pharmexpert»). «Doсtor Stoletov» is the winner of «Platinum ounce – 2007». PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Dmitry Godunov First Deputy General Director Pharmacy Chain «36.6» Education 1985 – 1990 – Moscow Academy of Federal Security Service. Field of study: Engineering. 1999 – 2001 Moscow State University for Economics, Statistics and Informatics. Field of study: Economics (Finances and loans) 2006 – present The Warwick Business School (The university of Warwick, England). Field of study: The Warwick MBA, Modular Study. To be completed in 2009 Professional Background 04.2001 – 06.2004 – veropharm (generics manufacturing, ~2500 employees): Deputy general director (Director for production) 06.2004 – 09.2006 – pharmacy Chain 36.6 First Deputy General Director - Chief Operating Officer 09.2006 – present – pharmacy Chain 36.6 (health&beauty retail) First Deputy General Director Company Profile Pharmacy Chain 36.6, founded in 1998, is the first Russian pharmaceutical company to go public. Today it is a leading Russian health & beauty retailer. 1168 pharmacies are currently under «36.6» management in 29 Russian regions today. The Company employs over 11000 qualified people and a strong management team with more than 10 years of the industry experience. 36,6 has its own manufacture OJSC «Veropharm», and also it possesses a chain of children toy shop – ELC (Early Learning Center). ZAO «Apteki 36.6» is a co-founder and a member of nonprofit professional organization Russian Association of Pharmacy Chains (RAPC). PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Alexander Kuzin General Director DSM Group Member of the European Society for Opinion and Market Research (ESOMAR) Education In 1996 Alexander graduated from Moscow Institute of Engineering and Physics majoring in Physics, and in 2002 he obtained his Master of Business Administration degree. Professional Background Starting from 1996 Alexander worked in the sphere of marketing management in the Russian pharmaceutical market. In 2004 he became General Director at DSM Group Company specializing in the sphere of marketing research and marketing support in the market of drugs, nutritional supplements, skin care products and para-pharmaceutics. In 2005 DSM Group became the first company in Russia that successfully certified the system of Russian pharmaceutical market retail audit quality management system according to ISO 9001:2000 international standards, and starting from 2006 all marketing research carried out by the DSM Group complies with ISO 9001:2000 requirements. Alexander is a member of the RAFM Pharmaceutical Marketing Experts Guild, a member of the Novaya Apteka (New Pharmacy) magazine editorial board and Moskovskie Apteki (Moscow Pharmacies) newspaper expert council. He is a winner of the National «Platinum Ounce» prize. Company Profile DSM Group has been in the market since 1999. The Agency offers a set of marketing services to Russian pharmaceutical market companies. DSM Group carries out retail audit of the Russian pharmaceutical market (the Quality Management System complies with the requirements of ISO 9001:2000), performs marketing research, regularly analyses the market capacity and trends covering them in a monthly reference book, conducts polls of pharmacies, focus-groups, performs custom research, and also provides advertising services. In 2006 DSM Group became a member of the European Society for Opinion and Market Research (ESOMAR). PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Alina Lavrentieva Partner, pharmaceutical industry leader PricewaterhouseCoopers Education Ph.D. in Economics, Certified Auditor. Professional Background Alina Lavrentieva is a partner of PricewaterhouseCoopers Russia B.V., one its leading specialists providing consulting for pharmaceutical companies and has extensive experience and knowledge in dealing with corporate tax and accounting issues. Prior to PricewaterhouseCoopers Russia B.V., Alina was the finance manager of a large multinational company and worked for a professional firm of advisors. Alina works closely with the Association of International Pharmaceutical Manufacturers in Russia (AIPM), taking active part in its finance committee work. She is chairperson of the Tax Committee of Association of European Businesses in the Russian Federation. Her clients include major pharmaceutical companies dealing in the Russian market. Company Profile PricewaterhouseCoopers works with a global network of firms that provide industry-focused insurance, tax and advisory services for pharmaceutical companies. Our team of over 1500 industry-dedicated professionals have broad knowledge and experience that allows us to offer optimal solutions. According to an annual rating published in Expert magazine, PricewaterhouseCoopers is the largest auditor, tax and legal advisor in Russia. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel David Melik-Gusseinov Marketing Research Director Pharmexpert Education He has two higher educations as a graduate from State Linguistic University majoring in linguistics and intercultural communication (2000) and State Pharmaceutical Academy majoring in pharmaceutics (2003). In 2007, he received his PhD degree in pharmaceutical science. He gives lectures on pharmaceutical marketing at the Higher School of Economics (Moscow). Professional Background David V. Melik-Gusseinov has been working in pharmaceutical business since 1998 (marketing, analytics, and consulting) Since 2003, he has been Head of Marketing Research Department at Pharmexpert. Key competence of the company includes creating analytical databases on pharmaceutical markets of Russia, CIS countries, and Eastern Europe, as well as a variety of marketing and sociological research and consulting. In 2007, Mr. Melik-Gusseinov was appointed Marketing Research Director. Since 2004, he has been a member of the Russian Association of Pharmaceutical Marketing. Mr. Melik-Gusseinov is the winner of national awards for professionals of Russian pharmaceutical industry such as «Platinum Ounce» as well as for Pharmaceutical Marketing, Advertisement and PR «Prescription of the Year». Company Profile In 1996 an information and analysis center was established at the Pharmatsevtichesky Vestnik (Pharmaceutical Herald) newspaper, which was renamed to the PharmExpert Center of Marketing Research in April 2000 (a member of Bionika Group of Companies). The PharmExpert CMR is a leader in the sphere of data collection and analysis in all segments of the Russian pharmaceutical market. In 2002 a representative office in Ukraine was founded, and in 2003 PharmExpert entered the markets of Belarus and Kazakhstan where it successfully provides a full range of products and services for different divisions of pharmaceutical companies. As of the end of 2007 the Center of Marketing Research also operates in Uzbekistan, Armenia, Georgia, Azerbaijan and Moldova. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Dr. László Pocsaji General Director EGIS Pharmaceuticals PLC (Hungary) in Russia Education In 1969, he graduated from Kharkov State University with a degree in solid-state physics. In 1972, Dr. Pocsaji defended his thesis on the philosophical aspects of modern physics. In 1976, he received his Ph.D. Professional Background His professional career began at the Scientific Research Institute of Metallophysics. Dr. Pocsaji took up various positions in the Ministry of Industry of Hungary from 1976 to 1986. He worked in the Hungary Chamber of Commerce in Russia from 1986 to 1993. Dr. Pocsaji has been a General Director of Representation of «EGIS Pharmaceuticals Plc.» (Hungary) in Russia since 1994. He has great experience as a member of different international scientific committees. He was the chairman of the European Economical Committee of Hungary under the United Nations. Dr. Pocsaji has been a member of the Council of National Representatives of the Association of European Businesses since 2006 and he is a head of the Trustee Council of the national award in the field of cardiology «Purple heart» since 2008. Dr. Pocsaji is a member of different international conferences and symposiums. Company Profile Egis Pharmaceuticals Plc was established 95 years ago and now is one of the largest pharmaceutical companies in Hungary that has had business in Russia since the early 1950s. Their production system meets the highest World Health Organization requirements and the international Good Manufacturing Practice principles. A strategic goal of the company is to make new pharmaceutical technologies and innovations of leading from European laboratories available for every Russian. Active investment, new technology development and strict quality control make it possible to meet European healthcare standards. For many years the company has been active in public policy in Russia, supported educational programs for doctors and social programs for patients, developed new innovative preparations in manufacturing. Egis Plc’s Russia representative has been recognized by International Award «Profession is life» (2004), the Golden diploma for the support of charitable actions for social problems (2005). It has been awarded the ‘International Gold Standard of Medicine, established by Russian Assembly of Health Foundation and approved by WHO (2008). Personnel at the companies Russian branch totals more than 400 people. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Vladimir Shipkov Executive Director Association of International Pharmaceutical Manufacturers Education In 1974 Vladimir graduated from the Military Institute of Foreign Languages. In 1991 he graduated from Russian State Humanities University. Professional Background Vladimir has a long experience of work in various governmental entities. He managed the Pharmaceutical Inspectorate of the Ministry of Health of the Russian Federation, worked in the capacity of deputy Head of the Federal Service for Intellectual Property, Patents and Trademarks, worked at the State Duma, the State Customs Committee, as well as in the banking sector. Company Profile Association of International Pharmaceutical Manufacturers (AIPM) is a non-profit organization that represents the interests of over 50 leading world pharmaceutical companies in Russia. AIPM sees its mission in contribution to and promotion of creating economic and legal conditions for the development of a civilized pharmaceutical market, increase of the medical care quality and diversification of the range of pharmaceuticals for the benefit of the Russian Federation population. AIPM members account for over 80% of the world drugs production, including a significant turnover in Russia. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Laszlo Sugar CEO Valenta («Otechestvennye lekarstva») Education Degree in economics and science Professional Background Extensive operational experience with more than 20 years in the pharmaceutical industry (Chemo Group, Actavis Hf). Mr. Sugar held high positions in both companies and was always able to be successful. In addition to vast experience in international corporations in various spheres of business, he also has experience in the Russian pharmaceutical business. Mr. Sugar is the foreign member of Russian Science Academy founding the generic trend in Russia. Currently Mr. Sugar is the CEO of «Valenta». Company Profile Valenta («Otechestvennye lekarstva») is the largest pharmaceutical manufacturer in Russia. Being the first means being fully responsible to our shareholders, business partners, consumers and employees. Over 5000 people are working during our holding today at the Novosibirsk and Schelkovo plants and at our head-quarters in Moscow. Medical representatives working in all large cities of Russia are among them. We want to use our work to prove the originality and quality of our medicines, corporate management and manufacturing standard, as well as the face that Valenta is not only the largest pharmaceutical company in Russia, but the best one. At the beginning of April, 2008, Valenta and Schelkovskii merged to create Valenta Pharmacevtika. This is to develop the company and its entry into the international market. Import to 18 countries accounts for 25% of the company’s total sales volume. Valenta has the power, appeal and ability to adapt to modern conditions. We are changing together with the world by moving with the time and market trends. We may have changed the name of our company, but we have not abandoned our main principles: developing innovative medicines, supporting the Russian sciences and investing the health of the nation. PHARMA RUSSIA FORUM Business during the epoch of changes 11 December 2008, Moscow, Marriott Grand Hotel Sergey Tsyb Director of the Department of Chemical and Technical Complex and Bioengineering Technologies Ministry of Industry and Trade of the Russian Federation Education Graduated from Plekhanov Russian Academy of Economics with honors. Professional Background In 1991-1996 – Commercial Director of the experimental inter-branch Scientific and Production Center «Apex», Moscow. In 1996 – 1999 – General Director, RKC LLC, Moscow. In 2000 – 2006 – General Director, Medopharmacenter CJSC, Moscow In 2006 – 2007 – General Director, Radiopreparat LLC, Moscow On 14 December 2007 in accordance with the order of the Ministry of Industry and Power of the Russian Federation No. 2363/k Sergey Tsyb was appointed to the position of Director of the Department of Chemical and Technical Complex and Bioengineering Technologies at the Ministry of Industry and Power of the RF. On 18 July 2008 in accordance with the order of the Ministry of Industry and Trade of the Russian Federation No. 178/k Sergey Tsyb was appointed to the position of Director of the Department of Chemical and Technical Complex and Bioengineering Technologies at the Ministry of Industry and Trade.
Pages to are hidden for
"PHARMA RUSSIA FORUM"Please download to view full document